Apyx Medical (APYX)
(Real Time Quote from BATS)
$1.12 USD
+0.06 (5.66%)
Updated Aug 13, 2024 12:56 PM ET
2-Buy of 5 2
C Value D Growth A Momentum C VGM
Price, Consensus and EPS Surprise
APYX 1.12 +0.06(5.66%)
Will APYX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APYX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for APYX
Apyx Medical (APYX) Reports Q2 Loss, Lags Revenue Estimates
Ayr Wellness Inc. (AYRWF) Reports Q2 Loss, Lags Revenue Estimates
APYX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Lags Revenue Estimates
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Other News for APYX
Renuvion Named #1 Trusted Body Contouring Technology by Doctors*
Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript
Apyx Medical price target lowered by $2 at Craig-Hallum, here's why
Lake Street Sticks to Its Buy Rating for Apyx Medical (APYX)
Apyx Medical (APYX) Receives a Hold from Piper Sandler